Miastenia bez tajemnic. Jak optymalnie diagnozować i leczyć w roku 2026.

Nils Erik Gilhus is Professor (emeritus) in neurology at University of Bergen, Norway since 1987 and a senior researcher at Haukeland University Hospital. He was a senior consultant in neurology from 1986, previous dean and head of department, and he has for many years played an active role in national and international scientific and health organizations. Gilhus has published more than 500 scientific papers, mainly on neuroimmunology and neuroepidemiology, centred on myasthenia gravis and epilepsy. He has supervised more than 30 accomplished PhDs and been a partner of 6 EU research projects, coordinating three of them

Elisabeth Chroni was born in Greece. She received her Medical Degree from the University of Patras, completed her Neurology training in Athens, and earned her PhD in Clinical Neurophysiology from the University of London in 1994. She further specialized in single-fiber electromyography (SF-EMG) at the Department of Clinical Neurophysiology, Uppsala University, in 2011.

She joined the University of Patras as a Lecturer in Neurology in 1989 and was appointed Full Professor in 2010. Since 2016, she has served as Director of the Department of Neurology and Head of the Neuromuscular Unit at the University Hospital of Patras, a center recognized as a National Centre of Excellence for Rare Diseases.

Professor Chroni was elected Head of the Neuromuscular Branch of the Hellenic Neurological Society for the periods 2016–2017 and 2023–2025. She has also served as the representative of the Hellenic Neurological Society in Peripheral Neuropathies and Clinical Neurophysiology Scientific Panels of the European Academy of Neurology from 2015 to 2024.

Her research output includes 186 publications with 4,120 citations and an H-index of 36. She has been an invited speaker at 62 scientific meetings, served on the organizing committee of five national conferences on myasthenia and myopathies, and acted as a reviewer for 50 peer-reviewed scientific journals. She has been Principal Investigator in 11 clinical trials focusing on CIDP, myasthenia gravis, neuropathies, and ALS, and a collaborator in four competitively funded European research grants.

Assoc. Prof. Viktorija Ķēniņa is a neurologist and Head Doctor of the Rare Neurological Disease Centre at Pauls Stradiņš Clinical University Hospital, Riga, Latvia. She is affiliated with Riga Stradiņš University, where she is involved in teaching and research in neuroimmunology and neuromuscular disorders. Her main clinical and scientific interests include myasthenia gravis, autoimmune neuropathies, and biomarkers in neuroimmunological diseases. She is actively involved in international collaborations and clinical research projects focusing on immune dysregulation and rare neurological diseases.

Prof. Tobias Ruck is Director of the Department of Neurology at BG University Hospital Bergmannsheil, Ruhr University Bochum, and heads the Heimer Institute for Muscle Research. He is a clinician–scientist specializing in neuroimmunology and neuromuscular disorders, with a translational research focus integrating histopathology, omics technologies, and biomarker-driven clinical studies. His work aims to bridge experimental discovery and patient-centered therapies, particularly in myasthenia gravis, inflammatory neuropathies, and muscle diseases.